- Home
- TIL vs NCTY Comparison
TIL vs NCTY Comparison
Compare TIL & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- NCTY
- Stock Information
- Founded
- TIL 2018
- NCTY 1999
- Country
- TIL United States
- NCTY China
- Employees
- TIL N/A
- NCTY N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- NCTY Business Services
- Sector
- TIL Health Care
- NCTY Consumer Discretionary
- Exchange
- TIL Nasdaq
- NCTY Nasdaq
- Market Cap
- TIL 171.7M
- NCTY 156.7M
- IPO Year
- TIL 2021
- NCTY 2004
- Fundamental
- Price
- TIL $26.95
- NCTY $9.36
- Analyst Decision
- TIL Buy
- NCTY
- Analyst Count
- TIL 5
- NCTY 0
- Target Price
- TIL $119.00
- NCTY N/A
- AVG Volume (30 Days)
- TIL 316.4K
- NCTY 89.6K
- Earning Date
- TIL 05-13-2025
- NCTY 01-01-0001
- Dividend Yield
- TIL N/A
- NCTY N/A
- EPS Growth
- TIL N/A
- NCTY N/A
- EPS
- TIL N/A
- NCTY N/A
- Revenue
- TIL N/A
- NCTY $15,305,175.00
- Revenue This Year
- TIL N/A
- NCTY N/A
- Revenue Next Year
- TIL N/A
- NCTY N/A
- P/E Ratio
- TIL N/A
- NCTY N/A
- Revenue Growth
- TIL N/A
- NCTY N/A
- 52 Week Low
- TIL $9.62
- NCTY $5.75
- 52 Week High
- TIL $92.00
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- TIL 65.08
- NCTY 32.45
- Support Level
- TIL $12.60
- NCTY $11.21
- Resistance Level
- TIL $35.28
- NCTY $11.95
- Average True Range (ATR)
- TIL 3.84
- NCTY 0.75
- MACD
- TIL 1.60
- NCTY -0.21
- Stochastic Oscillator
- TIL 63.27
- NCTY 8.21
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.